Matter
Bioalliance Pharma v Spepharm Holding BV and Spebio BV
French proceedings concerning an intermediate arbitral award in the BioAlliance Pharma dispute and the requirement to challenge it through an action to set aside.
Procedural record
- 8 April 2010Arbitration
8 April 2010Arbitration
Intermediate arbitral award
Participants
Bioalliance Pharma
Spepharm Holding B.V.
Spebio B.V.
1 year and 27 days later · 392 days
- 5 May 2011France
5 May 2011France
Judgment of the Paris Court of Appeal dated 5 May 2011
Paris Court of Appeal
- Decision summary
- The Paris Court of Appeal refused to join Bioalliance Pharma's appeal-nullity to its action to set aside the intermediate arbitral sentence, declared the appeal-nullity inadmissible, and ordered Bioalliance Pharma to pay costs and specified sums to Spepharm Holding B.V. and Spebio B.V.
Participants
Bioalliance Pharma
Spepharm Holding B.V.
Spebio B.V.
Paris Court of Appeal
2 years, 6 months and 1 day later · 916 days
- 6 November 2013France
6 November 2013France
Judgment of the French Court of Cassation, First Civil Chamber dated 6 November 2013
French Court of Cassation, First Civil Chamber
- Decision summary
- The Court of Cassation dismissed Bioalliance Pharma's appeal. It held that an exequatur order for an international arbitral sentence may be challenged through the action to set aside the sentence, so an exceptional appeal-nullity was unavailable.
Participants
Bioalliance Pharma
- Representative
- Me Bouthors (For: Bioalliance Pharma)
Spepharm Holding B.V.
Spebio B.V.
French Court of Cassation, First Civil Chamber